NFKBIA and cancer: In cancer microenvironments, the inhibitor of NFκB (IκBα) is phosphorylated and ubiquitinated, leading to a p65–p50 heterodimer translocating into the nucleus and binding with specific consensus sequences to activate downstream signaling transduction, including MMPs [44].